Jochen H. Lorch, MD, MS
Advertisement
Articles by Jochen H. Lorch, MD, MS
A key opinion leader reviews the case of a 71-year-old woman with NTRK gene fusion thyroid cancer and considers novel therapies available for the management of her disease.
Advertisement
Latest Updated Articles
Preferred Testing Methods and Treatment OptionsSeptember 21st 2020
- LOXO-101 Trial Regimen Overview
September 21st 2020
- A 71-Year-Old Woman With NTRK Gene Fusion Thyroid Cancer
September 21st 2020
- NTRK Gene Fusion Thyroid Cancer: Incidence and Prognosis
September 21st 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
3
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
4
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC
5